These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32648033)

  • 1. ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.
    Sicinska E; Kola VSR; Kerfoot JA; Taddei ML; Al-Ibraheemi A; Hsieh YH; Church AJ; Landesman-Bollag E; Landesman Y; Hemming ML
    Cancer Res; 2024 Jul; 84(14):2247-2264. PubMed ID: 38657118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alveolar Soft Part Sarcoma-The Angiogenic Mechanism Regulated by a Fusion Gene Product].
    Nakamura T; Tanaka M
    Gan To Kagaku Ryoho; 2024 Jun; 51(6):585-590. PubMed ID: 39009511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
    Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
    Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel canine soft tissue sarcoma cell line and comparison of its characteristics with other soft tissue sarcoma cell lines.
    Miyanishi K; Igase M; Murakami M; Sakai Y; Sakurai M; Tani K; Motegi T; Mizuno T
    Res Vet Sci; 2024 May; 171():105245. PubMed ID: 38554610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital alveolar soft part sarcoma: Histopathologic report of two cases.
    Alkatan H; Al-Shedoukhy AA; Chaudhry IA; Al-Ayoubi A
    Saudi J Ophthalmol; 2010 Apr; 24(2):57-61. PubMed ID: 23960876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.
    Mitton B; Federman N
    Sarcoma; 2012; 2012():428789. PubMed ID: 22566752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spare-Part Technique for Covering Soft Tissue Defects in Sarcoma: Clinical Utility and Review of Literature.
    Raja A; Nutakki M; Krishnan CK; Ramachandran V; Mahalingam S; Malik K; Kathiresan N
    Indian J Surg Oncol; 2023 Jun; 14(2):354-360. PubMed ID: 37324287
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of alveolar soft part sarcoma using a large national database.
    Hagerty BL; Aversa J; Diggs LP; Dominguez DA; Ayabe RI; Blakely AM; Davis JL; Luu C; Hernandez JM
    Surgery; 2020 Nov; 168(5):825-830. PubMed ID: 32703677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
    Isoyama S; Tamaki N; Noguchi Y; Okamura M; Yoshimatsu Y; Kondo T; Suzuki T; Yaguchi SI; Dan S
    Cell Death Dis; 2023 Feb; 14(2):169. PubMed ID: 36849535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
    Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
    Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Ono T; Toki S; Kobayashi E; Arakawa A; Sugiyama M; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
    Tsuji K; Ishikawa Y; Imamura T
    Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
    Guérin R; Menard AL; Angot E; Piton N; Vera P; Schwarz L; Sabourin JC; Laé M; Thiébaut PA
    Diagn Pathol; 2024 Apr; 19(1):62. PubMed ID: 38643139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar Soft Part Sarcoma.
    Jaber OI; Kirby PA
    Arch Pathol Lab Med; 2015 Nov; 139(11):1459-62. PubMed ID: 26516944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.